Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies ... - istockAnalyst.com (press release) |
 |
 |
|
istockAnalyst.com (press release) Affymax, Inc. (Nasdaq: AFFY) and Takeda Global Research & Development Center, Inc., US, today announced results from additional analyses of the EMERALD Phase 3 studies that evaluated the investigational agent peginesatide in dialysis patients with ... Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies ... MarketWatch (press release) Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies |
